Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Howard Jackson

Interventional Pain Medicine Temple Terrace, FL Medical Doctor

NPI 1255338042 CMS profile 147718

13020 N Telecom Pkwy, Temple Terrace, FL 33637

Open in the dashboard

General payments

$3,477

113 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Howard Jackson of Temple Terrace, FL is reported in the CMS Open Payments database as having received $3,477 across 113 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 47th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,035 24
2024 General $572 13
2023 General $1,198 16
2021 General $65 4
2020 General $232 18
2019 General $375 38

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Howard Jackson
  • Interventional Pain Medicine median
  • Middle half of Interventional Pain Medicine
  • National median

In program year 2025, general payments to Howard Jackson were reported at $1,035. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.

Show as a table
Year Howard Jackson Interventional Pain Medicine median Middle half National median
2019 $375 $684 $216–$2,079 $163
2020 $232 $382 $122–$1,109 $114
2021 $65 $552 $167–$1,554 $132
2022 $0 $605 $187–$1,924 $149
2023 $1,198 $671 $195–$1,915 $160
2024 $572 $684 $206–$1,837 $164
2025 $1,035 $657 $184–$1,753 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $1,441 29 payments
  2. Relievant Medsystems, Inc. $1,174 15 payments
  3. Horizon Therapeutics plc $412 39 payments
  4. Zyla Life Sciences $134 14 payments
  5. Pfizer Inc. $103 6 payments
  6. Vertex Pharmaceuticals Incorporated $47 2 payments
  7. Vertos Medical, Inc. $47 2 payments
  8. Scilex Pharmaceuticals Inc. $46 2 payments
  9. Protega Pharmaceutials LLC $45 2 payments
  10. Painteq LLC $28 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,738 110 payments
  2. Travel and Lodging $739 3 payments
Products named General payments · program years 2019–2025
  1. Intracept Pain $1,188 16 payments
  2. Intracept Pain $1,174 15 payments
  3. Intracept Pain $1,174 15 payments
  4. Intracept Pain $1,174 15 payments
  5. Intracept RF Probe $496 10 payments
  6. DUEXIS $344 34 payments
  7. WaveWriter Alpha Prime 16 $164 1 payment
  8. Intracept Intracept Access Instruments 2 VB (Gen 3)_NMOD $161 1 payment
  9. Intracept Intracept Access Instruments (Gen 3)_NMOD $83 6 payments
  10. ZORVOLEX $72 7 payments
  11. Other $459 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 22 drugs

Part D claims

6,549

Median for Interventional Pain Management: 1,220

Drug cost

$117,675

Median for Interventional Pain Management: $39,344

Branded share of claims

19.3%

Median for Interventional Pain Management: 34.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 1,454 $54,488
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 863 $12,738
Pregabalin Generic 446 $10,064
Gabapentin Generic 808 $9,086
Lidocaine Generic 48 $4,976
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 256 $4,216
Tramadol Hcl Generic 538 $3,681
Tizanidine Hcl Generic 284 $3,534
Nabumetone Generic 163 $2,587
Acetaminophen-Codeine Acetaminophen With Codeine Brand 146 $1,739

The 10 drugs with the highest cost, of 22 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,476 Part D prescribers listed as Interventional Pain Management; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$160,133

Medicare's payments for the services billed

Medicare patients

470

Average age 74

Services billed

1,877

271 women, 199 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 34%
Diabetes 32%
Depression 32%
Chronic kidney disease 28%
Osteoporosis 22%
COPD 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

113 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Pain Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record